RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Gross hematuria and kidney consequences after COVID-19 vaccination = 코로나바이러스-19 예방접종 이후 혈뇨와 신장 합병증에 관한 연구

      한글로보기

      https://www.riss.kr/link?id=T16857365

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      The coronavirus disease-19 (COVID-19) vaccination can result in kidney-related complications such as abnormal urine tests and reduced renal function, which are rare and can only be detected through testing. Macroscopic hematuria, a condition that is easily noticed without the need for special tests, is considered a cause for great concern for most individuals. The current study aimed to examine the frequency of kidney-related complications, with a specific focus on gross hematuria, and to determine its influence on the clinical course of kidney disease.
      The retrospective questionnaire survey was performed on the patients visiting Soonchunhyang University Cheonan Hospital's nephrology outpatient department between January 1 and September 30, 2022. The questionnaire included vaccine type, dosage, vaccination date, and complications, including gross hematuria and other systemic symptoms. If gross hematuria occurred, its duration was recorded, and the laboratory parameter was followed up.
      A total of 281 vaccinated patients with biopsy-proven glomerulonephritis, abnormal urinalysis, or chronic kidney disease were enrolled. Ten gross hematuria events were observed. All the cases were related to the mRNA vaccine (9 with mRNA-1273 of Moderna and 1 with BNT162b2 of Pfizer-BioNTech). Two patients experienced gross hematuria after the first dose of vaccination and eight cases after the second dose. The mean onset time was 1.6 ± 0.8 days, and the duration was 5.0 ± 4.8 days. Fever, headache, fatigue, and chilling were frequent accompanied symptoms. Five patients had already been diagnosed with Immunoglobulin A nephropathy by renal biopsy. Two of the Immunoglobulin A nephropathy patients experienced the aggravation of proteinuria after the gross hematuria event. Five patients were newly diagnosed with glomerulonephritis (3 of Immunoglobulin A nephropathy, 1 of minimal change disease) and systemic disease (1 of rhabdomyolysis).
      The mRNA COVID-19 vaccination could provoke gross hematuria and could be related to the new development or aggravation of glomerulonephritis. Physicians should recognize the potential harm of vaccination and carefully monitor kidney function after the gross hematuria event.
      번역하기

      The coronavirus disease-19 (COVID-19) vaccination can result in kidney-related complications such as abnormal urine tests and reduced renal function, which are rare and can only be detected through testing. Macroscopic hematuria, a condition that is e...

      The coronavirus disease-19 (COVID-19) vaccination can result in kidney-related complications such as abnormal urine tests and reduced renal function, which are rare and can only be detected through testing. Macroscopic hematuria, a condition that is easily noticed without the need for special tests, is considered a cause for great concern for most individuals. The current study aimed to examine the frequency of kidney-related complications, with a specific focus on gross hematuria, and to determine its influence on the clinical course of kidney disease.
      The retrospective questionnaire survey was performed on the patients visiting Soonchunhyang University Cheonan Hospital's nephrology outpatient department between January 1 and September 30, 2022. The questionnaire included vaccine type, dosage, vaccination date, and complications, including gross hematuria and other systemic symptoms. If gross hematuria occurred, its duration was recorded, and the laboratory parameter was followed up.
      A total of 281 vaccinated patients with biopsy-proven glomerulonephritis, abnormal urinalysis, or chronic kidney disease were enrolled. Ten gross hematuria events were observed. All the cases were related to the mRNA vaccine (9 with mRNA-1273 of Moderna and 1 with BNT162b2 of Pfizer-BioNTech). Two patients experienced gross hematuria after the first dose of vaccination and eight cases after the second dose. The mean onset time was 1.6 ± 0.8 days, and the duration was 5.0 ± 4.8 days. Fever, headache, fatigue, and chilling were frequent accompanied symptoms. Five patients had already been diagnosed with Immunoglobulin A nephropathy by renal biopsy. Two of the Immunoglobulin A nephropathy patients experienced the aggravation of proteinuria after the gross hematuria event. Five patients were newly diagnosed with glomerulonephritis (3 of Immunoglobulin A nephropathy, 1 of minimal change disease) and systemic disease (1 of rhabdomyolysis).
      The mRNA COVID-19 vaccination could provoke gross hematuria and could be related to the new development or aggravation of glomerulonephritis. Physicians should recognize the potential harm of vaccination and carefully monitor kidney function after the gross hematuria event.

      더보기

      목차 (Table of Contents)

      • 1. Introduction 1
      • 2. Materials and Methods 3
      • 3. Results 5
      • 4. Discussion 8
      • 5. Conclusion 10
      • 1. Introduction 1
      • 2. Materials and Methods 3
      • 3. Results 5
      • 4. Discussion 8
      • 5. Conclusion 10
      • REFERENCES 18
      • 국문요약 22
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼